BSA
WST icon

Braun Stacey Associates’s West Pharmaceutical WST Stock Holding History

Braun Stacey Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-745
Closed -$211K – 150
2020
Q4 		$211K Hold
745
– – 0.01% 129
2020
Q3 		$205K Buy
+745
New +$197K 0.01% 124

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Braun Stacey Associates's WST Position: Q1 2021 in Review

Braun Stacey Associates sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 745 shares — an estimated $211K sold.

Braun Stacey Associates first reported a position in WST in Q3 2020 and held it in 2 quarters. The position peaked at $211K in Q4 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Braun Stacey Associates reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 745 West Pharmaceutical shares in Q1 2021, an estimated $211K.
  • Braun Stacey Associates first reported a position in West Pharmaceutical in Q3 2020 and held it in 2 quarters.
  • Braun Stacey Associates's West Pharmaceutical position peaked at $211K in Q4 2020.
  • 590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Braun Stacey Associates's 13F filing for Q1 2021, filed 28 Apr 2021.